HRT can also be a concern after treatment. If you’ve been treated for HR+ breast cancer, “There is always some small risk ...
FDA approves beetroot red and expands spirulina extract use in many foods and allows no artificial colors labeling while ...
Eikon was founded in 2019 by Chemistry Nobel Prize winner Eric Betzig, along with Xavier Darzacq, Luke Lavis and Robert ...
City St. George’s researchers identified 9 genetic signatures and epigenetic changes driving lapatinib resistance in HER2-positive breast cancer. Cancer scientists from City St George’s, University of ...
Award-winning presentation recognizes AI-CVD-HF heart failure prediction model leveraging coronary artery calcium (CAC) scans HONG KONG, January 27, 2026 /EINPresswire.com/ — HeartLung AI announced ...
A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled "Silent toxicity: A rare case of ...
Japanese pharmaceutical giant Eisai has forged an oncology licensing deal worth up to $388m with Shanghai Henlius Biotech. Through this deal, Eisai will pay $75m up front for the rights to develop and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results